In the clinical setting, for HER2-positive BC brain metastasis survival times between 10 and 25 months are reported after radiotherapy, involving whole brain (WBRT) or stereotactic radiotherapy (SRT) [44–46]. Here, ERBB2 is linked to metastasis.